RAP has enter the respiratory management for Asthma and COPD market for their other product to screen for attack and allow them to manage their medical dosage more accurately which also has massive revenue potential, wheezing doesn't mean you are having Asthma attack or even Asthma......
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-8
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
-0.002(6.67%) |
Mkt cap ! $32.10M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 3.0¢ | 2.8¢ | $6.177K | 219.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 486755 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 121551 | 1 |
View Market Depth
| Last trade - 13.30pm 17/07/2024 (20 minute delay) ? |
| RSH (ASX) Chart |